חזרה לתוצאות החיפוש

Donanemab (LY3002813) Trial in Chinese Participants With Cognitively Unimpaired (Preclinical) Alzheimer's Disease

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE3

מצבים רפואיים

Alzheimer Disease

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

  • Peking University Third Hospital, Beijing, China

    Contact: Principal Investigator (Qiong Yang)

  • The First Hospital of Jilin University, Changchun, China

    Study coordinator · 13504313689
    Contact: Principal Investigator (Li Sun)

  • Xiangya Hospital Central South University, Changsha, China

    Study coordinator · 073189753041
    Contact: Principal Investigator (Lu Shen)

  • Sichuan Provincial People's Hospital, Chengdu, China

    Contact: Principal Investigator (Nengwei Yu)

  • 2nd Affiliated Hospital Chongqing Medical University, Chongqing, China

    Study coordinator · +86 13032327639
    Contact: Principal Investigator (Xiaofeng Li)

  • The First Affiliated Hospital of Chongqing Medical University, Chongqing, China

    Study coordinator · +86 13618236535
    Contact: Principal Investigator (Yang Lv)

  • Fujian Medical University Union Hospital, Fuzhou, China

    Study coordinator · 18149568903
    Contact: Principal Investigator (Jiawei Xin)

  • Guangdong Provincial People's Hospital, Guangzhou, China

    Contact: Principal Investigator (jiehao zhao)

  • Anhui Provincial Hospital, Hefei, China

    Contact: Principal Investigator (Zhaozhao Cheng)

  • The Second Hospital of Jiaxing, Jiaxing, China

    Contact: Principal Investigator (Yanping Wang)

  • Jinan Central Hospital, Jinan, China

    Study coordinator · 15318816109
    Contact: Principal Investigator (Hong Bian)

  • The Second Affiliated Hospital of Nanchang University, Nanchang, China

    Contact: Principal Investigator (Zhenyu Tang)

  • Jiangsu Province Official Hospital, Nanjing, China

    Contact: Principal Investigator (Kezhong Zhang)

  • Nanjing Brain Hospital, Nanjing, China

    Study coordinator · 13372003816
    Contact: Principal Investigator (Weiwei Jiang)

  • Sir Run Run Hospital of Nanjing Medical University, Nanjing, China

    Contact: Principal Investigator (Xiang Lu)

  • The First Affiliated Hospital of Nanyang Medical College, Nanyang, China

    Contact: Principal Investigator (Qian Deng)

  • Shanghai Sixth People's Hospital, Shanghai, China

    Study coordinator · 02124056429
    Contact: Principal Investigator (Qihao Guo)

  • Shanghai East Hospital, Shanghai, China

    Contact: Principal Investigator (You Yin)

  • Renji Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, China

    Contact: Principal Investigator (Gang Wang)

  • Huashan Hospital, Fudan University, Shanghai, China

    Study coordinator · 021-111111
    Contact: Principal Investigator (Jintai Yu)

  • Pudong New Area People's Hospital Shanghai, Shanghai, China

    Study coordinator · 021-20509000
    Contact: Principal Investigator (Xiaohui Zhao)

  • ShenZhen People's Hospital, Shenzhen, China

    Study coordinator · +86 13662205122
    Contact: Principal Investigator (Liangyu Zou)

  • The First Hospital of Hebei Medical University, Shijiazhuang, China

    Study coordinator · 0311-87155010
    Contact: Principal Investigator (Xiaowei Ma)

  • Tianjin Medical University General Hospital, Tianjin, China

    Study coordinator · 022-6036225
    Contact: Principal Investigator (Li Yang)

  • The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China

    Contact: Principal Investigator (Zhen Wang)

  • Shaanxi provincial people's hospital, Xi'an, China

    Contact: Principal Investigator (Rui Li)

  • Xianyang Hospital of Yan'an University, Xianyang, China

    Study coordinator · 13572769709
    Contact: Principal Investigator (Aihong Guo)

  • Qinghai Provincial People's Hospital, Xining, China

    Contact: Principal Investigator (Xin Zhong)

  • Zigong First People's Hospital, Zigong, China

    Study coordinator · 15983171312
    Contact: Principal Investigator (Xiaoya Xu)

  • Zunyi First People's Hospital, Zunyi, China

    Contact: Principal Investigator (Fei Feng)
מובילי המחקר

  • Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)

    Study Director

    Eli Lilly and Company

צפייה במקור ב־ClinicalTrials.gov(נפתח בחלון חדש)